483 Amphastar Pharmaceuticals Oct 2002

483 Amphastar Pharmaceuticals Oct 2002

Jennifer Gogley FDA, Caryn Mcnab FDA, Kim Thomas Cruse FDA$595.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observations (via FDA 483) on 09 Oct 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Oct 2002
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart